Rhythm Pharmaceuticals, Inc. (RYTM)
88.69
+0.58
(+0.66%)
USD |
NASDAQ |
Apr 17, 16:00
88.67
-0.02
(-0.02%)
Pre-Market: 08:28
Rhythm Pharmaceuticals SG&A Expense (Quarterly) : 57.48M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 2.364M |
| Eli Lilly & Co. | 3.132B |
| Merck & Co., Inc. | 2.898B |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| MannKind Corp. | 58.41M |